New Leaf Venture Partners, L.L.C. - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 12 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
New Leaf Venture Partners, L.L.C. ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$1,317,000
-11.8%
352,9500.0%0.94%
-12.3%
Q3 2016$1,493,000
+8.4%
352,9500.0%1.08%
-9.3%
Q2 2016$1,377,000352,9501.18%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 5,095,354$5250.06%
TKG Advisors, LLC 134,860$13,8910.01%
GPS Wealth Strategies Group, LLC 253,205$25,3210.01%
Performa Ltd (US), LLC 70,000$7,2100.00%
Genesee Capital Advisors, LLC 19,860$2,0460.00%
Garden State Investment Advisory Services LLC 30,000$3,0900.00%
MAI Capital Management 617,733$63,6260.00%
Twin Lakes Capital Management, LLC 12,500$1,2880.00%
DRIVE WEALTH MANAGEMENT, LLC 10,000$1,0300.00%
Boyd Wealth Management, LLC 12,180$1,2550.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders